234 related articles for article (PubMed ID: 6692402)
1. Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone.
Shiu RP; Paterson JA
Cancer Res; 1984 Mar; 44(3):1178-86. PubMed ID: 6692402
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells.
Dembinski TC; Leung CK; Shiu RP
Cancer Res; 1985 Jul; 45(7):3083-9. PubMed ID: 4005846
[TBL] [Abstract][Full Text] [Related]
3. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice.
Leung CK; Shiu RP
Cancer Res; 1981 Feb; 41(2):546-51. PubMed ID: 7448802
[TBL] [Abstract][Full Text] [Related]
4. Progesterone-specific stimulation of triglyceride biosynthesis in a breast cancer cell line (T-47D).
Judge SM; Chatterton RT
Cancer Res; 1983 Sep; 43(9):4407-12. PubMed ID: 6871874
[TBL] [Abstract][Full Text] [Related]
5. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D).
Leroy-Martin B; Peyrat JP
Anticancer Res; 1989; 9(3):631-6. PubMed ID: 2764510
[TBL] [Abstract][Full Text] [Related]
6. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture.
Myal Y; Shiu RP; Bhaumick B; Bala M
Cancer Res; 1984 Dec; 44(12 Pt 1):5486-90. PubMed ID: 6093996
[TBL] [Abstract][Full Text] [Related]
7. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture.
Biswas R; Vonderhaar BK
Cancer Res; 1987 Jul; 47(13):3509-14. PubMed ID: 3581086
[TBL] [Abstract][Full Text] [Related]
8. Prolactin receptors in human breast tumors.
Turcot-Lemay L; Kelly PA
J Natl Cancer Inst; 1982 Mar; 68(3):381-3. PubMed ID: 6278192
[TBL] [Abstract][Full Text] [Related]
9. Prolactin-inducible proteins in human breast cancer cells.
Shiu RP; Iwasiow BM
J Biol Chem; 1985 Sep; 260(20):11307-13. PubMed ID: 2863272
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells.
Ng KW; Livesey SA; Larkins RG; Martin TJ
Cancer Res; 1983 Feb; 43(2):794-800. PubMed ID: 6184157
[TBL] [Abstract][Full Text] [Related]
11. Different elements of mini-helix 1 are required for human growth hormone or prolactin action via the prolactin receptor.
Peterson FC; Brooks CL
Protein Eng Des Sel; 2004 May; 17(5):417-24. PubMed ID: 15252206
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.
Reddel RR; Murphy LC; Sutherland RL
Cancer Res; 1984 Jun; 44(6):2398-405. PubMed ID: 6722780
[TBL] [Abstract][Full Text] [Related]
13. A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.
Chen WY; Ramamoorthy P; Chen N; Sticca R; Wagner TE
Clin Cancer Res; 1999 Nov; 5(11):3583-93. PubMed ID: 10589775
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells.
Cataldo L; Chen NY; Yuan Q; Li W; Ramamoorthy P; Wagner TE; Sticca RP; Chen WY
Int J Oncol; 2000 Dec; 17(6):1179-85. PubMed ID: 11078803
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M induces cell detachment and enhances the metastatic capacity of T-47D human breast carcinoma cells.
Jorcyk CL; Holzer RG; Ryan RE
Cytokine; 2006 Mar; 33(6):323-36. PubMed ID: 16713283
[TBL] [Abstract][Full Text] [Related]
16. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone binding to cultured human breast cancer cells.
Murphy LJ; Vrhovsek E; Sutherland RL; Lazarus L
J Clin Endocrinol Metab; 1984 Jan; 58(1):149-56. PubMed ID: 6315757
[TBL] [Abstract][Full Text] [Related]
18. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
Gutzman JH; Miller KK; Schuler LA
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
[TBL] [Abstract][Full Text] [Related]
19. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.
Tanaka T; Shiu RP; Gout PW; Beer CT; Noble RL; Friesen HG
J Clin Endocrinol Metab; 1980 Nov; 51(5):1058-63. PubMed ID: 7419681
[TBL] [Abstract][Full Text] [Related]
20. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
